<?xml version="1.0" encoding="UTF-8"?>
<p>For virus infection, BMDMs were infected with ZIKV at 1 MOI with or without ZY13 and Amodiaquine (AQ, A2799, Sigma, Burlington, MA, United States) administration. AQ is an FDA-approved drug and can effectively inhibit ZIKV infection in neural progenitor cells both 
 <italic>in vitro</italic> and in a mouse model (
 <xref rid="B51" ref-type="bibr">Zhou et al., 2017</xref>). Twenty four hours post infection, cells were lysed in TRIzol reagent for RNA isolation and further analysis.
</p>
